https://m2.mtmt.hu/ hun 2026-10-24 01:10 JournalArticle 36125656 VALIDATED true Funding Agency and Grant Number: Hungarian Brain Research Program [KTIA_NAP_13-2-2015-0001, 2017-1.2.1NKP-2017-00002]; Hungarian Brain Research Program 3.0 [NAP2022-I-4/2022]; MTA-SE Neuropsychopharmacology and Neurochemistry Research Group; Thematic Excellence Program of the Ministry for Innovation and Technology in Hungary [TKP2021-EGA-25]; ERA-NET COFUND Program [2019-2.1.7-ERA-NET-2020-00005]; New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund [UNKP-23-4-I-SE31]; International Short-term Exchange Program for Young Researchers by the ICR-iJURC, Kyoto University [EFOP-3.6.3VEKOP-16-2017-00009]; Japan Society for the Promotion of Science Postdoctoral Fellowships for Research in Japan [P20809] Funding text: The authors also would like to thank Dorottya Papp, Gyongyi Kokonyei, Andrea Edes, David Kovacs, Terezia Zsombok, Mate Magyar, Natalia Kocsel, Lajos Kozak, Adam Bekesy-Szabo, Edina Szabo, Attila Galambos, volunteers, and the nurses for their contribution to the study. This study has been supported by: the Hungarian Brain Research Program (KTIA_NAP_13-2-2015-0001, 2017-1.2.1NKP-2017-00002); Hungarian Brain Research Program 3.0 (NAP2022-I-4/2022); MTA-SE Neuropsychopharmacology and Neurochemistry Research Group; Thematic Excellence Program of the Ministry for Innovation and Technology in Hungary (TKP2021-EGA-25); ERA-NET COFUND Program (2019-2.1.7-ERA-NET-2020-00005); New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund (UNKP-23-4-I-SE31); International Short-term Exchange Program for Young Researchers by the ICR-iJURC, Kyoto University; EFOP-3.6.3VEKOP-16-2017-00009; and Japan Society for the Promotion of Science Postdoctoral Fellowships for Research in Japan, standard program, P20809 for Peter Petschner. The sponsors funded the work but had no further role in the design of the study, in data collection or analysis, in the decision to publish, or in the preparation, review, or approval of the manuscript. 0 false 2026-10-10T16:22:38.586+0000 2025-10-13T09:45:47.182+0000 2025-05-08T09:19:29.569+0000 true 10030040 Ruzsits Ágnes /api/admin/10030040 Admin Ruzsits Ágnes (SE_GYTK_Gyhatástan_Admin5_RÁ, admin) true 10030040 2026-09-10T12:10:12.564+0000 2025-09-01T13:08:15.188+0000 true 10062062 Gere Tamásné /api/admin/10062062 Admin Gere Tamásné (SE_KK_Admin5_GT, admin) true 10062062 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Kumar, Sahel true true /api/journal/10074087 REVIEWED PAIN REPORTS 2471-2531 true false 10074087 false 10074087 true 2471-2531 Journal FOREIGN 10 3 e1254 e1254 9 2025 Funding 2052885 /api/funding/2052885 Hungarian Brain Research Program(KTIA_NAP_13-2-2015-0001) false true Funding 2052886 /api/funding/2052886 (NAP2017-1.2.1-NKP-2017-00002) false true Funding 2052887 /api/funding/2052887 Hungarian Brain Research Program(NAP2022-I-4/2022) false true Funding 2052888 /api/funding/2052888 (2019-2.1.7-ERA-NET-2020-00005) Támogató: Nemzeti Kutatási, Fejlesztési és Innovációs Hivatal false true Funding 2052889 /api/funding/2052889 (ÚNKP-23-4-I-SE-31) false true Funding 2052890 /api/funding/2052890 (EFOP-3.6.3-VEKOP-16-2017-00009) false true true 2025 true true true false false NONE 2026-10-10 false 1 0 1 1 0 1 1 0 1 1 1 1 1 1 0 0 1 1 1 1 0 5 5 Folyóiratcikk Journal Article 24 1 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2026 0 1 1 1 1 Q1 false false false false 2025-05-14T11:14:40.624+0000 Gyógyszerhatástani Intézet (SE / GYTK); NAP3.0-SE Neuropszichofarmakológiai Kutatócsoport (SE / GYTK / GYHATAS) 5 17 2 5 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 126397874 /api/authorship/126397874 Kumar, Sahel [Kumar, Sahel (Pharmacology), szerző] Gyógyszerhatástani Intézet (SE / GYTK) 1 0.2 true false false Author 10068484 /api/author/10068484 Kumar Sahel (Pharmacology) Kumar Sahel true true Kumar Sahel true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 126397875 /api/authorship/126397875 Petschner, Péter* ✉ [Petschner, Péter (Farmakológia), szerző] Gyógyszerhatástani Intézet (SE / GYTK) 2 0.2 true false true Author 10024138 /api/author/10024138 Petschner Péter (Farmakológia) Petschner Péter true 10024138 true Petschner Péter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 126397876 /api/authorship/126397876 Gecse, Kinga [Gecse, Kinga (Farmakológia és I...), szerző] Gyógyszerhatástani Intézet (SE / GYTK); NAP3.0-SE Neuropszichofarmakológiai Kutatócsoport (SE / GYTK / GYHATAS) 3 0.2 false false false Author 10068445 /api/author/10068445 Gecse Kinga (Farmakológia és Idegtudományok) Gecse Kinga true true Gecse Kinga true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 126397877 /api/authorship/126397877 Török, Dóra [Török, Dóra (pszichiátriai gen...), szerző] Gyógyszerhatástani Intézet (SE / GYTK) 4 0.2 false false false Author 10075294 /api/author/10075294 Török Dóra (pszichiátriai genetika) Török Dóra true true Török Dóra true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 126397878 /api/authorship/126397878 Juhász, Gabriella [Juhász, Gabriella (Neurológia), szerző] Gyógyszerhatástani Intézet (SE / GYTK); NAP3.0-SE Neuropszichofarmakológiai Kutatócsoport (SE / GYTK / GYHATAS) 5 0.2 false true false Author 10017483 /api/author/10017483 Juhász Gabriella (Neurológia) Juhász Gabriella true 10017483 true Juhász Gabriella true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 29322926 /api/publicationidentifier/29322926 DOI: 10.1097/PR9.0000000000001254 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1097/PR9.0000000000001254 https://doi.org/10.1097/PR9.0000000000001254 false true PublicationIdentifier 29396179 /api/publicationidentifier/29396179 WoS: 001483870300001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001483870300001 https://www.webofscience.com/wos/woscc/full-record/001483870300001 true true PublicationIdentifier 29397287 /api/publicationidentifier/29397287 Scopus: 105004708524 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 105004708524 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105004708524 true true PublicationIdentifier 29322928 /api/publicationidentifier/29322928 PubMed: 40322023 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 40322023 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40322023&dopt=Abstract false true SjrRating 11554241 /api/sjrrating/11554241 sjr:Q1 (2025) Scopus - Anesthesiology and Pain Medicine PAIN REPORTS 2471-2531 17 0.24 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2703 /api/classificationexternal/2703 Scopus - Anesthesiology and Pain Medicine true 2703 true Q1 DIRECT true true Reference 65700970 /api/reference/65700970 1. Ahting 2025: Incorporating nanopore sequencing into a diverse diagnostic toolkit for incontinentia pigmenti., Human Mutation, DOI: 10.1155/humu/6657400 1 10.1155/humu/6657400 false true Reference 65700971 /api/reference/65700971 2. Attenburrow 2001: Low-dose citalopram as a 5-HT neuroendocrine probe., Psychopharmacology (Berl)., 155, p. 323, DOI: 10.1007/s002130100729 2 10.1007/s002130100729 false true Reference 65700972 /api/reference/65700972 3. Bardaro 2003: Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKgamma dene deletion., Hum Mutat, 21, p. 8, DOI: 10.1002/humu.10150 3 10.1002/humu.10150 false true Reference 65700973 /api/reference/65700973 4. Bekhbat 2017: Checks and balances: the glucocorticoid receptor and NFĸB in good times and bad., Front Neuroendocrinol, 46, p. 15, DOI: 10.1016/j.yfrne.2017.05.001 4 10.1016/j.yfrne.2017.05.001 false true Reference 65700974 /api/reference/65700974 5. Bhagwagar 2002: Acute citalopram administration produces correlated increases in plasma and salivary cortisol., Psychopharmacology (Berl)., 163, p. 118, DOI: 10.1007/s00213-002-1149-4 5 10.1007/s00213-002-1149-4 false true Reference 65700975 /api/reference/65700975 6. Borsook 2012: Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load., Neuron, 73, p. 219, DOI: 10.1016/j.neuron.2012.01.001 6 10.1016/j.neuron.2012.01.001 false true Reference 65700976 /api/reference/65700976 7. Chappell 2007: Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx., Anesthesiology, 107, p. 776, DOI: 10.1097/01.anes.0000286984.39328.96 7 10.1097/01.anes.0000286984.39328.96 false true Reference 65700977 /api/reference/65700977 8. Chappell 2009: TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin., Basic Res Cardiol, 104, p. 78, DOI: 10.1007/s00395-008-0749-5 8 10.1007/s00395-008-0749-5 false true Reference 65700978 /api/reference/65700978 9. Clayton 2018: The role of microRNAs in glucocorticoid action., J Biol Chem, 293, p. 1865, DOI: 10.1074/jbc.R117.000366 9 10.1074/jbc.R117.000366 false true Reference 65700979 /api/reference/65700979 10. de Kloet 2005: Stress and the brain: from adaptation to disease., Nat Rev Neurosci, 6, p. 463, DOI: 10.1038/nrn1683 10 10.1038/nrn1683 false true Reference 65700980 /api/reference/65700980 11. Dickerson 2004: Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research., Psychol Bull, 130, p. 355, DOI: 10.1037/0033-2909.130.3.355 11 10.1037/0033-2909.130.3.355 false true Reference 65700981 /api/reference/65700981 12. Dodick 2009: Review of comorbidities and risk factors for the development of migraine complications (infarct and chronic migraine)., Cephalalgia, 29, p. 7 12 false true Reference 65700982 /api/reference/65700982 13. Froese 2006: Innate immune responses in NF-kappaB-repressing factor-deficient mice., Mol Cell Biol, 26, p. 293, DOI: 10.1128/MCB.26.1.293-302.2006 13 10.1128/MCB.26.1.293-302.2006 false true Reference 65700983 /api/reference/65700983 14. Fusco 2012: Genomic architecture at the Incontinentia Pigmenti locus favours de novo pathological alleles through different mechanisms., Hum Mol Genet, 21, p. 1260, DOI: 10.1093/hmg/ddr556 14 10.1093/hmg/ddr556 false true Reference 65700984 /api/reference/65700984 15. Gallardo 2023: A study of differential microRNA expression profile in migraine: the microMIG exploratory study., J Headache Pain, 24, p. 11, DOI: 10.1186/s10194-023-01542-z 15 10.1186/s10194-023-01542-z false true Reference 65700985 /api/reference/65700985 16. Gazerani 2019: Current evidence on potential uses of MicroRNA biomarkers for migraine: from diagnosis to treatment., Mol Diagn Ther, 23, p. 681, DOI: 10.1007/s40291-019-00428-8 16 10.1007/s40291-019-00428-8 false true Reference 65700986 /api/reference/65700986 17. Gecse 2022: Association of plasma tryptophan concentration with periaqueductal gray matter functional connectivity in migraine patients., Sci Rep, 12, p. 739, DOI: 10.1038/s41598-021-04647-0 17 10.1038/s41598-021-04647-0 false true Reference 65700987 /api/reference/65700987 18. Gecse 2022: Citalopram neuroendocrine challenge shows altered tryptophan and kynurenine metabolism in migraine., Cells, 11, p. 2258, DOI: 10.3390/cells11142258 18 10.3390/cells11142258 false true Reference 65700988 /api/reference/65700988 19. Harder 2021: Metabolic profile changes in serum of migraine patients detected using 1H-NMR spectroscopy., J Headache Pain, 22, p. 142, DOI: 10.1186/s10194-021-01357-w 19 10.1186/s10194-021-01357-w false true Reference 65700989 /api/reference/65700989 20. Het 2012: Stress-induced cortisol level elevations are associated with reduced negative affect after stress: indications for a mood-buffering cortisol effect., Psychosom Med, 74, p. 23, DOI: 10.1097/PSY.0b013e31823a4a25 20 10.1097/PSY.0b013e31823a4a25 false true Reference 65700990 /api/reference/65700990 21. Holm 1997: Migraine and stress: a daily examination of temporal relationships in women migraineurs., Headache, 37, p. 553, DOI: 10.1046/j.1526-4610.1997.3709553.x 21 10.1046/j.1526-4610.1997.3709553.x false true Reference 65700991 /api/reference/65700991 22. Holsboer 2010: Stress hormone regulation: biological role and translation into therapy., Annu Rev Psychol, 61, p. 81, DOI: 10.1146/annurev.psych.093008.100321 22 10.1146/annurev.psych.093008.100321 false true Reference 65700992 /api/reference/65700992 23. Huang 2003: Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress., Cell, 115, p. 565, DOI: 10.1016/S0092-8674(03)00895-X 23 10.1016/S0092-8674(03)00895-X false true Reference 65700993 /api/reference/65700993 24. Kelman 2007: The triggers or precipitants of the acute migraine attack., Cephalalgia, 27, p. 394, DOI: 10.1111/j.1468-2982.2007.01303.x 24 10.1111/j.1468-2982.2007.01303.x false true Reference 65700994 /api/reference/65700994 25. Kocsel 2019: Altered neural activity to monetary reward/loss processing in episodic migraine., Sci Rep, 9, p. 5420, DOI: 10.1038/s41598-019-41867-x 25 10.1038/s41598-019-41867-x false true Reference 65700995 /api/reference/65700995 26. Kokonyei 2019: Anticipation and violated expectation of pain are influenced by trait rumination: an fMRI study., Cogn Affect Behav Neurosci, 19, p. 56, DOI: 10.3758/s13415-018-0644-y 26 10.3758/s13415-018-0644-y false true Reference 65700996 /api/reference/65700996 27. Krause 2021: Hormonal influences in migraine-interactions of oestrogen, oxytocin and CGRP., Nat Rev Neurol, 17, p. 621, DOI: 10.1038/s41582-021-00544-2 27 10.1038/s41582-021-00544-2 false true Reference 65700997 /api/reference/65700997 28. Kumagai 2009: Role of glycocalyx in flow-induced production of nitric oxide and reactive oxygen species., Free Radic Biol Med, 47, p. 600, DOI: 10.1016/j.freeradbiomed.2009.05.034 28 10.1016/j.freeradbiomed.2009.05.034 false true Reference 65700998 /api/reference/65700998 29. Li 2014: System wide analyses have underestimated protein abundances and the importance of transcription in mammals., PeerJ, 2, p. e270, DOI: 10.7717/peerj.270 29 10.7717/peerj.270 false true Reference 65700999 /api/reference/65700999 30. Lipton 2014: Reduction in perceived stress as a migraine trigger: testing the “let-down headache” hypothesis., Neurology, 82, p. 1395, DOI: 10.1212/WNL.0000000000000332 30 10.1212/WNL.0000000000000332 false true Reference 65701000 /api/reference/65701000 31. Lotrich 2005: Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences., Psychopharmacology (Berl)., 178, p. 268, DOI: 10.1007/s00213-004-2006-4 31 10.1007/s00213-004-2006-4 false true Reference 65701001 /api/reference/65701001 32. Mallawaarachchi 2016: Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney disease., Eur J Hum Genet, 24, p. 1584, DOI: 10.1038/ejhg.2016.48 32 10.1038/ejhg.2016.48 false true Reference 65701002 /api/reference/65701002 33. Mochizuki 2003: Role of hyaluronic acid glycosaminoglycans in shear-induced endothelium-derived nitric oxide release., Am J Physiol Heart Circ Physiol, 285, p. H722, DOI: 10.1152/ajpheart.00691.2002 33 10.1152/ajpheart.00691.2002 false true Reference 65701003 /api/reference/65701003 34. Nadeem 2004: Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses., Neuropsychopharmacology, 29, p. 1699, DOI: 10.1038/sj.npp.1300475 34 10.1038/sj.npp.1300475 false true Reference 65701004 /api/reference/65701004 35. Nater 2013: Biomarkers of stress in behavioural medicine., Curr Opin Psychiatry, 26, p. 440, DOI: 10.1097/YCO.0b013e328363b4ed 35 10.1097/YCO.0b013e328363b4ed false true Reference 65701005 /api/reference/65701005 36. Neeb 2007: Nitric oxide in migraine., CNS Neurol Disord Drug Targets, 6, p. 258, DOI: 10.2174/187152707781387233 36 10.2174/187152707781387233 false true Reference 65701006 /api/reference/65701006 37. Olesen 1994: Nitric oxide is a key molecule in migraine and other vascular headaches., Trends Pharmacol Sci, 15, p. 149, DOI: 10.1016/0165-6147(94)90075-2 37 10.1016/0165-6147(94)90075-2 false true Reference 65701007 /api/reference/65701007 38. Olnes 2016: Effects of systemically administered hydrocortisone on the human immunome., Sci Rep, 6, p. 23002, DOI: 10.1038/srep23002 38 10.1038/srep23002 false true Reference 65701008 /api/reference/65701008 39. Peroutka 2014: What turns on a migraine? A systematic review of migraine precipitating factors., Curr Pain Headache Rep, 18, p. 454, DOI: 10.1007/s11916-014-0454-z 39 10.1007/s11916-014-0454-z false true Reference 65701009 /api/reference/65701009 40. Pradhan 2018: Targeted nitric oxide synthase inhibitors for migraine., Neurotherapeutics, 15, p. 391, DOI: 10.1007/s13311-018-0614-7 40 10.1007/s13311-018-0614-7 false true Reference 65701010 /api/reference/65701010 41. Reitsma 2007: The endothelial glycocalyx: composition, functions, and visualization., Pflugers Archiv, 454, p. 345, DOI: 10.1007/s00424-007-0212-8 41 10.1007/s00424-007-0212-8 false true Reference 65701011 /api/reference/65701011 42. Russell 2019: The human stress response., Nat Rev Endocrinol, 15, p. 525, DOI: 10.1038/s41574-019-0228-0 42 10.1038/s41574-019-0228-0 false true Reference 65701012 /api/reference/65701012 43. Schenck 2021: The role of the glycocalyx in the pathophysiology of subarachnoid hemorrhage-induced delayed cerebral ischemia., Front Cell Dev Biol, 9, p. 731641, DOI: 10.3389/fcell.2021.731641 43 10.3389/fcell.2021.731641 false true Reference 65701013 /api/reference/65701013 44. Schulte 2016: The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks., Brain, 139, p. 1987, DOI: 10.1093/brain/aww097 44 10.1093/brain/aww097 false true Reference 65701014 /api/reference/65701014 45. Schulte 2020: Longitudinal neuroimaging over 30 days: temporal characteristics of migraine., Ann Neurol, 87, p. 646, DOI: 10.1002/ana.25697 45 10.1002/ana.25697 false true Reference 65701015 /api/reference/65701015 46. Sheehan 1998: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10., J Clin Psychiatry, 59, p. 22 46 false true Reference 65701016 /api/reference/65701016 47. Spierings 2001: Precipitating and aggravating factors of migraine versus tension-type headache., Headache, 41, p. 554, DOI: 10.1046/j.1526-4610.2001.041006554.x 47 10.1046/j.1526-4610.2001.041006554.x false true Reference 65701017 /api/reference/65701017 48. Stark 2019: RNA sequencing: the teenage years., Nat Rev Genet, 20, p. 631, DOI: 10.1038/s41576-019-0150-2 48 10.1038/s41576-019-0150-2 false true Reference 65701018 /api/reference/65701018 49. Stewart 2001: Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability., Neurology, 56, p. S20, DOI: 10.1212/WNL.56.suppl_1.S20 49 10.1212/WNL.56.suppl_1.S20 false true Reference 65701019 /api/reference/65701019 50. Stubberud 2021: Is there a causal relationship between stress and migraine? Current evidence and implications for management., J Headache Pain, 22, p. 155, DOI: 10.1186/s10194-021-01369-6 50 10.1186/s10194-021-01369-6 false true Reference 65701020 /api/reference/65701020 51. Subramanian 2005: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles., Proc Natl Acad Sci U S A, 102, p. 15545, DOI: 10.1073/pnas.0506580102 51 10.1073/pnas.0506580102 false true Reference 65701021 /api/reference/65701021 52. Szabó 2019: Association between migraine frequency and neural response to emotional faces: an fMRI study., Neuroimage Clin, 22, p. 101790, DOI: 10.1016/j.nicl.2019.101790 52 10.1016/j.nicl.2019.101790 false true Reference 65701022 /api/reference/65701022 53. Vives-Mestres 2021: Patterns of perceived stress throughout the migraine cycle: a longitudinal cohort study using daily prospective diary data., Headache, 61, p. 90, DOI: 10.1111/head.13943 53 10.1111/head.13943 false true Reference 65701023 /api/reference/65701023 54. Xu 2022: A preliminary study on change of serum immunoglobulin G glycosylation in patients with migraine., Front Neurol, 13, p. 860555, DOI: 10.3389/fneur.2022.860555 54 10.3389/fneur.2022.860555 false true Reference 65701024 /api/reference/65701024 55. Yen 2015: Endothelial surface glycocalyx can regulate flow-induced nitric oxide production in microvessels in vivo., PLoS One, 10, p. e0117133, DOI: 10.1371/journal.pone.0117133 55 10.1371/journal.pone.0117133 false true Reference 65701025 /api/reference/65701025 56. Zanotti 2015: ATAD5 deficiency decreases B cell division and gh recombination., J Immunol, 194, p. 35, DOI: 10.4049/jimmunol.1401158 56 10.4049/jimmunol.1401158 false true /api/publication/36125656 Kumar Sahel et al. Acute neuroendocrine challenge elicits enhanced cortisol response and parallel transcriptomic changes in patients with migraine. (2025) PAIN REPORTS 2471-2531 10 3<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10068484"><a href="/gui2/?type=authors&mode=browse&sel=10068484" target="_blank">Kumar Sahel (<span class="authorship-author-name">Kumar Sahel</span> <span class="authorAux-mtmt"> Pharmacology</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Gyógyszerésztudományi Kar">GYTK</span>/Gyógyszerhatástani Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10024138"><a href="/gui2/?type=authors&mode=browse&sel=10024138" target="_blank">Petschner Péter^* ✉ (<span class="authorship-author-name">Petschner Péter</span> <span class="authorAux-mtmt"> Farmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Gyógyszerésztudományi Kar">GYTK</span>/Gyógyszerhatástani Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10068445"><a href="/gui2/?type=authors&mode=browse&sel=10068445" target="_blank">Gecse Kinga (<span class="authorship-author-name">Gecse Kinga</span> <span class="authorAux-mtmt"> Farmakológia és Idegtudományok</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Gyógyszerésztudományi Kar">GYTK</span>/Gyógyszerhatástani Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Gyógyszerésztudományi Kar">GYTK</span>/<span title="Gyógyszerhatástani Intézet">GYHATAS</span>/NAP3.0-SE Neuropszichofarmakológiai Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10075294"><a href="/gui2/?type=authors&mode=browse&sel=10075294" target="_blank">Török Dóra (<span class="authorship-author-name">Török Dóra</span> <span class="authorAux-mtmt"> pszichiátriai genetika</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Gyógyszerésztudományi Kar">GYTK</span>/Gyógyszerhatástani Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10017483"><a href="/gui2/?type=authors&mode=browse&sel=10017483" target="_blank">Juhász Gabriella (<span class="authorship-author-name">Juhász Gabriella</span> <span class="authorAux-mtmt"> Neurológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Gyógyszerésztudományi Kar">GYTK</span>/Gyógyszerhatástani Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Gyógyszerésztudományi Kar">GYTK</span>/<span title="Gyógyszerhatástani Intézet">GYHATAS</span>/NAP3.0-SE Neuropszichofarmakológiai Kutatócsoport</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;36125656" target="_blank">Acute neuroendocrine challenge elicits enhanced cortisol response and parallel transcriptomic changes in patients with migraine</a></div> <div> <span class="journal-title">PAIN REPORTS</span> <span class="journal-issn">( <a target="_blank" href="https://portal.issn.org/resource/ISSN/2471-2531">2471-2531</a>)</span>: <span class="journal-volume">10</span> <span class="journal-issue">3</span> <span class="page"> Paper e1254. 9 p. </span> <span class="year">(2025)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1097/PR9.0000000000001254" target="_blank" href="https://doi.org/10.1097/PR9.0000000000001254"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001483870300001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001483870300001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="105004708524" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105004708524"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="40322023" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40322023&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Anesthesiology and Pain Medicine&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 1</span> | Független: 1 | Függő: 0 | Nem jelölt: 0 | Scopus jelölt:&nbsp;1 | WoS/Scopus jelölt:&nbsp;1 | DOI jelölt:&nbsp;1 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;36125656&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 5 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 36125656</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> Hungarian Brain Research Program(KTIA_NAP_13-2-2015-0001), (NAP2017-1.2.1-NKP-2017-00002), Hungarian Brain Research Program(NAP2022-I-4/2022), (2019-2.1.7-ERA-NET-2020-00005) Támogató: Nemzeti Kutatási, Fejlesztési és Innovációs Hivatal, (ÚNKP-23-4-I-SE-31), (EFOP-3.6.3.-VEKOP-16-2017-00009) </div> <div class="lastModified">Utolsó módosítás: 2025.10.13. 11:45 Áncsán Gizella (SE admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Funding Agency and Grant Number: Hungarian Brain Research Program [KTIA_NAP_13-2-2015-0001, 2017-1.2.1NKP-2017-00002]; Hungarian Brain Research Program 3.0 [NAP2022-I-4/2022]; MTA-SE Neuropsychopharmacology and Neurochemistry Research Group; Thematic Excellence Program of the Ministry for Innovation and Technology in Hungary [TKP2021-EGA-25]; ERA-NET COFUND Program [2019-2.1.7-ERA-NET-2020-0000...</pre> </div></div>